The University of the Philippines (UP), in partnership with UP Manila NIH National Telehealth Center and cooperation with UP Philippine General Hospital (PGH), invites you to join the fight against COVID-19.
The Omicron variant is now the dominant SARS-CoV-2 variant in the Philippines. Amid the early 2022 surge, thankfully, more COVID-19 medications have sprung up, such as molnupiravir, Paxlovid, remdesivir, and more.
Are these safe and effective treatments against COVID-19? What are the dangers of self-medication and online buying of certain unrecommended drugs? How can we make these accessible and readily available for everyone?
This week’s episode of the UP “Stop COVID Deaths” webinar series, titled “COVID-19 Medications: Epektibo Ba?” will discuss the latest updates on the virus, vaccines, and prescribed medicines. Dr. Edsel Maurice Salvaña, Director of the Institute of Molecular Biology and Biotechnology of the UP Manila-National Institutes of Health, and a member of the Department of Health’s Technical Advisory Group, will be the main speaker.
Dr. Mary Ann Lansang, esteemed infectious diseases specialist and clinical epidemiologist, and Dr. Maria Ofelia Ocana-Alcantara, mayor of the municipality of Tolosa, Leyte, will also be part of this week’s webinar’s panel.
Register here and catch our weekly live tweets and streams via the UP System Twitter Account and TVUP’s YouTube channel and Facebook page, and stay on top of the facts, the evidence, and the science on the treatment of COVID-19.
The UP “Stop COVID Deaths” webinar series is the Philippines’ first and only frontline-focused medical webinar series. It pioneered the discussion, dissemination, and adoption of knowledge on COVID-19 treatment and management. Follow our accounts to stay connected with your credible online community.